Sign In
Buy IVVD
$1.10
-0.0400 (-3.51%)
At Close: Jun 03, 2026
Adagio Therapeutics to Participate in Upcoming Investor Conferences
04:01pm, Tuesday, 06'th Sep 2022
WALTHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of d
Hedge Fund M28 Capital Increases Adagio Therapeutics (ADGI) Stake to 8.5%
08:08pm, Monday, 22'nd Aug 2022
Last Friday, health care focused hedge fund M28 Capital filed a 13D/A with the US Securities & Exchange Committee revealing it bought 2.85 million Adagio Therapeutics (US:ADGI) at an average of $4.28
Adagio's (ADGI) COVID-19 Antibody Meets Goals in Studies
01:33pm, Thursday, 31'st Mar 2022
The stock price of Adagio (ADGI) surge after it reports positive preliminary data from the phase II/III studies, which evaluate its monoclonal antibody for the prevention and treatment of COVID-19.
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
01:41pm, Wednesday, 30'th Mar 2022
Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, G
Adagio's COVID-19 Antibody Meets Primary Goals Across Pre & Post-Exposure Prophylaxis, Treatment
11:27am, Wednesday, 30'th Mar 2022
Adagio Therapeutics Inc's (NASDAQ: ADGI) Phase 2/3 trials evaluating 300 mg adintrevimab (ADG20) as pre-and-post-exposure prophylaxis (EVADE) and treatment (STAMP) for COVID-19 have met its primary
Why Adagio Therapeutics Stock Is Soaring Today
10:50am, Wednesday, 30'th Mar 2022
Investors are reacting to better than expected clinical trial results for its COVID-19 treatment candidate.
Why Adagio Therapeutics Stock Is Soaring Today
10:23am, Wednesday, 30'th Mar 2022
Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the first monoclonal antibody to meet primary endpoin
Adagio Stock Spikes on New Data, but Its Omicron Problems Remain
09:33am, Wednesday, 30'th Mar 2022
Adagio Therapeutics says it will seek an emergency use authorization for its Covid-19 antibody, known as ADG20, in the second quarter.
Trading Penny Stocks? Top Stock Market News for March 30th, 2022
09:30am, Wednesday, 30'th Mar 2022
Here's what you need to know about trading penny stocks on March 30th The post Trading Penny Stocks? Top Stock Market News for March 30th, 2022 appeared first on Penny Stocks to Buy, Picks, News and I
2 Net Current Asset Value Stocks to Consider
05:32pm, Wednesday, 23'rd Mar 2022
There are some investors who buy U.S.-listed stocks that are trading below their liquidation value because they believe there is a lot to gain in these stocks after the market reprices shares to near
Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention
03:10pm, Wednesday, 16'th Feb 2022
Three recent independent in-vitro studies show that ADG20 has neutralization activity against Omicron.
12 biotech stocks to consider buying now as prospects for the sector brighten this year
04:53pm, Sunday, 06'th Feb 2022
Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double
Top 5 IPOs of 2021
07:05pm, Friday, 04'th Feb 2022
Digital World Acquisition, ZIM Integrated Shipping Services, Adagio Therapeutics, Roblox, and Doximity saw the largest percentage increase in stock price since initial listing.
Why Shares of Adagio Therapeutics Soared 25.9% on Thursday
05:05pm, Thursday, 20'th Jan 2022
The clinical-stage biotech company is working on an antiviral treatment to fight multiple variants of COVID-19.
5 Top Biotech Stocks To Watch In January 2022
02:30pm, Sunday, 16'th Jan 2022
Could these biotech stocks be poised for gains in 2022?
